Nortriptyline Hydrochloride recalls
Nortriptyline Hydrochloride products have been recalled 1 time, most recently on 10 Feb 2021. The recalling company is usually Taro Pharmaceuticals U. The most common reason is manufacturing (cgmp) deviations.
Total recalls1since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 10 Feb 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why nortriptyline hydrochloride is recalled
Companies
By year
All nortriptyline hydrochloride recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nortriptyline HCl Capsules, USP equivalent to 10mg base recalledNortriptyline Hydrochloride | Taro Pharmaceuticals U | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.